Synthesis and antitumour activity of new derivatives of flavone-8-acetic acid (FAA). Part 2: Ring-substituted derivatives

Archiv der Pharmazie

Volumn 330, Issue 7, 1997, Pages 215-224

  Aitken, R Alan ^a   Bibby, Michael C ^b   Double, John A ^b   Laws, Andrea L ^b   Ritchie, Robert B ^a   Wilson, David W J ^a  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

Antitumour activity; Flavone acetic acid; Structure activity relationships; Synthesis

Indexed keywords

FLAVONE DERIVATIVE; MITOFLAXONE;

ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROPHOTOMETRY; INTRAPERITONEAL DRUG ADMINISTRATION; MASS SPECTROMETRY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; COLONIC NEOPLASMS; DRUG SCREENING ASSAYS, ANTITUMOR; FLAVONOIDS; HUMANS; MICE; TUMOR CELLS, CULTURED;

EID: 0030865738     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/ardp.19973300706     Document Type: Article

References (38)

1. G. Atassi, P. Briet, J.-J. Berthelon, F. Collonges, Eur. J. Med. Chem. 1985, 20, 393-402.
2. J. Plowman, V. L. Narayanan, D. Dykes, E. Szarvasi, P. Briet, O. C. Yoder, K. D. Paull, Cancer Treat. Rep. 1986, 70, 361-365; T. H. Corbett, M. C. Bissery, A. Wozniak, J. Plowman, L. Polin, E. Tapazoglou, J. Dickman, F. Valeriote, Invest. New Drugs 1986, 4, 207-220.
3. J. Plowman, V. L. Narayanan, D. Dykes, E. Szarvasi, P. Briet, O. C. Yoder, K. D. Paull, Cancer Treat. Rep. 1986, 70, 361-365; T. H. Corbett, M. C. Bissery, A. Wozniak, J. Plowman, L. Polin, E. Tapazoglou, J. Dickman, F. Valeriote, Invest. New Drugs 1986, 4, 207-220.
4. M. C. Bibby, J. A. Double, R. M. Phillips, P. M. Loadman, Br. J. Cancer 1987, 55, 159-163.
5. D. J. Kerr, T. Maughan, E. Newlands, G. Rustin, N. M. Bleehen, C. Lewis, S. B. Kaye, Br. J. Cancer 1989, 60, 104-106; M. C. Bibby, J. A. Double, Anti-Cancer Drugs 1993, 4, 3-17.
6. D. J. Kerr, T. Maughan, E. Newlands, G. Rustin, N. M. Bleehen, C. Lewis, S. B. Kaye, Br. J. Cancer 1989, 60, 104-106; M. C. Bibby, J. A. Double, Anti-Cancer Drugs 1993, 4, 3-17.
7. G. W. Rewcastle, personal communication.
8. R. A. Aitken, M. C. Bibby, J. A. Double, R. M. Phillips, S. K. Sharma, Arch. Pharm. Pharm. Med. Chem. 1996, 329, 489-197.
9. M. C. Bibby, J. A. Double, R. M. Phillips, P. M. Loadman, J. A. Gummer in Progress in Clinical and Biological Research (Eds. V. Cody, E. Middleton, Jr., J. B. Harborne, A. Beretz), Alan R. Liss Inc., 1988, 280, 243-246.
10. W. A. Denny, B. C. Baguley, G. J. Atwell, G. W. Rewcastle, Eur. Pat. 278 176, 1988 [Chem. Abstr. 1989, 110, 8048]
11. T. Takahashi, T. Oshika, J. Pharm. Soc. Jpn. 1954, 74, 48-51.
12. P. Briet, J.-J. Berthelon, F. Colloges, Eur. Pat. 80 934, 1983 [Chem. Abstr. 1983, 99, 175594];
13. D. Dauzonne and L. Martinez, Tetrahedron Lett. 1995, 36, 1845-1848.
14. D. L. Dexter, J. A. Barbosa, P. Calabresi, Cancer Res. 1979, 39, 1020-1025.
15. W. A. F. Tompkins, A. M. Watrach, J. D. Schmale, R. M. Shultz, J. A. Harris, J. Natl. Cancer Inst. 1974, 52, 1001-1110.
16. C. B. Lozzio, B. B. Lozzio, Blood 1975, 45, 321.
17. S. A. B. Jabbar, P. R. Twentyman, J. V. Watson, Br. J. Cancer. 1989, 60, 523-528.
18. W. Mayer, R. Fikentscher, Chem. Ber. 1958, 91, 1536-1541.
19. A. Fölsing, Ber. Dtsch. Chem. Ges. 1884, 17, 486-488.
20. E. Hübner, Monatsh. Chem. 1894, 15, 719-738.
21. A. Ladenburg, A. Fitz, Liebigs Ann. Chem. 1867, 141, 247-260.
22. H. Fischli, Ber. Dtsch. Chem. Ges. 1879, 12, 615-622.
23. P. Pfeiffer, I. Engelhardt, W. Alfuss, Liebigs Ann. Chem. 1928, 467, 158-190.
24. A. Praxmarer, Monatsh. Chem. 1906, 27, 1199-1209.
25. W. H. Perkin, E. Schiess, J. Chem. Soc. 1904, 85, 159-165.
26. H. B. Henbest, J. A. W. Reid, C. J. M. Stirling, J. Chem. Soc. 1961, 5239-5244.
27. K. Freudenberg, W. Jakob, Ber. Dtsch. Chem. Ges. 1941, 74, 1001-1002.
28. J. Herzig, S. Epstein, Monatsh. Chem. 1908, 29, 661-675.
29. G. Barger, J. Chem. Soc. 1908, 93, 563-573.
30. R. Kuhn, H. R. Hensel, Ber. Dtsch. Chem. Ges. 1951, 84, 557-562.
31. K. Brand, H. Pabst, J. Prakt. Chem. 1929, 120, 199-213.
32. W. Will, Ber. Dtsch. Chem. Ges. 1888, 21, 2020-2026.
33. B. J. Ralph, A. Robertson, J. Chem. Soc. 1950, 3380-3383.
34. A. M. Hamburg, Monatsch. Chem. 1898, 19, 593-608.
35. F. Dallacker, Liebigs Ann. Chem. 1963, 665, 78-83.
36. P. Briet, J.-J. Berthelon, F. Collonges, B. Miribel, U.S. Pat. 4 602 034, 1986.
37. P. Briet, J.-J. Berthelon, F. Collonges, Eur. Pat. 341 104, 1989 [Chem. Abstr. 1990, 113, 23516].
38. R. I. Geran, N. H. Greenberg, M. M. MacDonald, A. M. Schumacher, B. J. Abbott, Cancer Chemother. Rep. 1972, 3, 1-103.